435 related articles for article (PubMed ID: 18049425)
1. Herpes simplex virus-2 and HIV among noninjecting drug users in New York city.
Des Jarlais DC; Hagan H; Arasteh K; McKnight C; Perlman D; Friedman SR
Sex Transm Dis; 2007 Nov; 34(11):923-7. PubMed ID: 18049425
[TBL] [Abstract][Full Text] [Related]
2. Convergence of HIV seroprevalence among injecting and non-injecting drug users in New York City.
Des Jarlais DC; Arasteh K; Perlis T; Hagan H; Abdul-Quader A; Heckathorn DD; McKnight C; Bramson H; Nemeth C; Torian LV; Friedman SR
AIDS; 2007 Jan; 21(2):231-5. PubMed ID: 17197815
[TBL] [Abstract][Full Text] [Related]
3. Decline in Herpes Simplex Virus Type 2 Among Non-Injecting Heroin and Cocaine Users in New York City, 2005 to 2014: Prospects for Avoiding a Resurgence of Human Immunodeficiency Virus.
Des Jarlais DC; Arasteh K; Feelemyer J; McKnight C; Tross S; Perlman DC; Campbell AN; Hagan H; Cooper HL
Sex Transm Dis; 2017 Feb; 44(2):85-90. PubMed ID: 27898577
[TBL] [Abstract][Full Text] [Related]
4. Sexual and other noninjection risks for HBV and HCV seroconversions among noninjecting heroin users.
Neaigus A; Gyarmathy VA; Zhao M; Miller M; Friedman SR; Des Jarlais DC
J Infect Dis; 2007 Apr; 195(7):1052-61. PubMed ID: 17330797
[TBL] [Abstract][Full Text] [Related]
5. Herpes simplex virus type-2 and human immunodeficiency virus infections in a rural population in Kilimanjaro Tanzania.
Mmbaga EJ; Leyna GH; Stray-Pedersen B; Klepp KI
East Afr J Public Health; 2011 Mar; 8(1):28-32. PubMed ID: 22066279
[TBL] [Abstract][Full Text] [Related]
6. Seroprevalence of herpes simplex virus type 2 and characteristics associated with undiagnosed infection: New York City, 2004.
Schillinger JA; McKinney CM; Garg R; Gwynn RC; White K; Lee F; Blank S; Thorpe L; Frieden T
Sex Transm Dis; 2008 Jun; 35(6):599-606. PubMed ID: 18418295
[TBL] [Abstract][Full Text] [Related]
7. Genital herpes simplex virus infection and perinatal transmission of human immunodeficiency virus.
Chen KT; Segú M; Lumey LH; Kuhn L; Carter RJ; Bulterys M; Abrams EJ;
Obstet Gynecol; 2005 Dec; 106(6):1341-8. PubMed ID: 16319261
[TBL] [Abstract][Full Text] [Related]
8. The interaction between herpes simplex virus and human immunodeficiency virus.
Celum CL
Herpes; 2004 Apr; 11 Suppl 1():36A-45A. PubMed ID: 15115628
[TBL] [Abstract][Full Text] [Related]
9. HSV-2 co-infection as a driver of HIV transmission among heterosexual non-injecting drug users in New York City.
Des Jarlais DC; Arasteh K; McKnight C; Perlman DC; Feelemyer J; Hagan H; Cooper HL
PLoS One; 2014; 9(1):e87993. PubMed ID: 24498235
[TBL] [Abstract][Full Text] [Related]
10. Methadone treatment protects against HIV infection: two decades of experience in the Bronx, New York City.
Hartel DM; Schoenbaum EE
Public Health Rep; 1998 Jun; 113 Suppl 1(Suppl 1):107-15. PubMed ID: 9722816
[TBL] [Abstract][Full Text] [Related]
11. Relative prevalence of different sexually transmitted infections in HIV-discordant sexual partnerships: data from a risk network study in a high-risk New York neighbourhood.
Friedman SR; Bolyard M; Sandoval M; Mateu-Gelabert P; Maslow C; Zenilman J
Sex Transm Infect; 2008 Feb; 84(1):17-8. PubMed ID: 17728340
[TBL] [Abstract][Full Text] [Related]
12. High risk of human immunodeficiency virus in men who have sex with men with herpes simplex virus type 2 in the EXPLORE study.
Brown EL; Wald A; Hughes JP; Morrow RA; Krantz E; Mayer K; Buchbinder S; Koblin B; Celum C
Am J Epidemiol; 2006 Oct; 164(8):733-41. PubMed ID: 16896053
[TBL] [Abstract][Full Text] [Related]
13. Hepatitis C virus infection among noninjecting drug users in New York City.
Koblin BA; Factor SH; Wu Y; Vlahov D
J Med Virol; 2003 Jul; 70(3):387-90. PubMed ID: 12767001
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of herpes simplex virus type 2 infection, human immunodeficiency virus/herpes simplex virus type 2 coinfection, and associated risk factors in a national, population-based survey in Kenya.
Mugo N; Dadabhai SS; Bunnell R; Williamson J; Bennett E; Baya I; Akinyi N; Mohamed I; Kaiser R
Sex Transm Dis; 2011 Nov; 38(11):1059-66. PubMed ID: 21992985
[TBL] [Abstract][Full Text] [Related]
15. Human immunodeficiency virus-1 infection correlates strongly with herpes simplex virus-2 (genital herpes) seropositivity in South African and United States blood donations.
Benjamin RJ; Busch MP; Fang CT; Notari EP; Puren A; Schoub BD; Tobler LH; Hogrefe W; du P Heyns A; Stramer SL; Crookes RL
Transfusion; 2008 Feb; 48(2):295-303. PubMed ID: 18005322
[TBL] [Abstract][Full Text] [Related]
16. Herpes simplex virus type 2 (HSV-2) seroprevalence at the time of HIV-1 diagnosis and seroincidence after HIV-1 diagnosis in an ethnically diverse cohort of HIV-1-infected persons.
Ramaswamy M; Sabin C; McDonald C; Smith M; Taylor C; Geretti AM
Sex Transm Dis; 2006 Feb; 33(2):96-101. PubMed ID: 16432480
[TBL] [Abstract][Full Text] [Related]
17. Sexual transmission risk among noninjecting heroin users infected with human immunodeficiency virus or hepatitis C virus.
Neaigus A; Miller M; Friedman SR; Des Jarlais DC
J Infect Dis; 2001 Aug; 184(3):359-63. PubMed ID: 11443564
[TBL] [Abstract][Full Text] [Related]
18. Population prevalence of reported and unreported HIV and related behaviors among the household adult population in New York City, 2004.
Nguyen TQ; Gwynn RC; Kellerman SE; Begier E; Garg RK; Pfeiffer MR; Konty KJ; Torian L; Frieden TR; Thorpe LE
AIDS; 2008 Jan; 22(2):281-7. PubMed ID: 18097231
[TBL] [Abstract][Full Text] [Related]
19. Epidemiology of genital herpes - recent advances.
Halioua B; Malkin JE
Eur J Dermatol; 1999; 9(3):177-84. PubMed ID: 10210781
[TBL] [Abstract][Full Text] [Related]
20. Sero-prevalence of Herpes simplex virus type 2 (HSV-2) in Rakai district, Uganda.
Emonyi IW; Gray RH; Zenilman J; Schmidt K; Wawer MJ; Sewankambo KN; Serwadda D; Kiwanuka N; Nalugoda F
East Afr Med J; 2000 Aug; 77(8):428-30. PubMed ID: 12862067
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
